Drug Pipeline

Fezolinetant Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
8
Active Studies
4
Recruiting
3
Phase 3
7
Top Sponsors
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-06-06 NCT06049797
A Study Following Women in Menopause Treated With a Non-hormonal Therapy for Hot Flashes…
Trial completed
New Trial Filings, Last 30 Days
First PostedTrialPhaseStatus
2026-05-26 NCT07606664 Fezolinetant and Vascular Health and Brain Health Phase 3 Not Yet Recruiting
2026-05-22 NCT07602530 A Study in Canada to Follow Outcomes of Women in Menopause Treated With Fezolinetant for… Recruiting
Active Studies by Phase
Phase 3
2
Phase 2/3
1
Phase 2
3
Not specified
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06440967 A Study to Confirm if Fezolinetant Helps Reduce Hot Flashes in Women With Breast Cancer… Hot Flashes Active, Not Recruiting
NCT07606664 Fezolinetant and Vascular Health and Brain Health Menopause Hot Flashes Not Yet Recruiting
Phase 2/3
NCT06975111 Focusing on the Menopausal Transition to Improve Mid-Life Women's Health Menopause Recruiting
Phase 2
NCT06972875 Fezolinetant for Treating Hot Flashes in Men With Prostate Cancer Prostate CA Recruiting
NCT06917313 FLASH-Breast: Evaluating the Efficacy of Fezolinetant in Reducing Vasomotor Symptoms in… Breast Cancer Early Stage Breast Cancer (Stage 1-3) Recruiting
NCT07568236 A Trial on Fezolinetant for Vasomotor Symptoms in Men Receiving Androgen Deprivation… Vasomotor Symptoms Not Yet Recruiting
Not specified
NCT07602530 A Study in Canada to Follow Outcomes of Women in Menopause Treated With Fezolinetant for… Hot Flashes Recruiting
NCT07455812 A Study in Germany to Learn About the Value of Fezolinetant in Treating Hot Flashes and… Hot Flashes Active, Not Recruiting
Sponsors Running Fezolinetant Trials
Disease Areas
Get alerts when Fezolinetant trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free